Citations (112)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (35)
Yujin Zhao, Chang Huang, Zhutian Zhang, Jiaxu Hong, Jianjiang Xu, Xinghuai Sun & Jianguo Sun. (2022) Sustained release of brimonidine from BRI@SR@TPU implant for treatment of glaucoma. Drug Delivery 29:1, pages 613-623.
Read now
Read now
Aditya Belamkar, Alon Harris, Ryan Zukerman, Brent Siesky, Francesco Oddone, Alice Verticchio Vercellin & Thomas A. Ciulla. (2022) Sustained release glaucoma therapies: Novel modalities for overcoming key treatment barriers associated with topical medications. Annals of Medicine 54:1, pages 343-358.
Read now
Read now
Ian Tapply & David C Broadway. (2021) Improving Adherence to Topical Medication in Patients with Glaucoma. Patient Preference and Adherence 15, pages 1477-1489.
Read now
Read now
Sandy Kim, Betty Tong, Jessica Lee, Darara Borodge & Karanjit Kooner. (2021) Lifestyle Counseling for Medication Adherence in Glaucoma. Clinical Ophthalmology 15, pages 3521-3529.
Read now
Read now
Deep Shikha Sharma, Sheetu Wadhwa, Monica Gulati, Arya Kadukkattil Ramanunny, Ankit Awasthi, Sachin Kumar Singh, Rubiya Khursheed, Leander Corrie, Nitin Chitranshi, Vivek Kumar Gupta & Sukriti Vishwas. (2021) Recent advances in intraocular and novel drug delivery systems for the treatment of diabetic retinopathy. Expert Opinion on Drug Delivery 18:5, pages 553-576.
Read now
Read now
Paula Anne Newman-Casey, Olivia Killeen, Sarah Miller, Chamisa MacKenzie, Leslie M. Niziol, Ken Resnicow, John W. Creswell, Paul Cook & Michele Heisler. (2020) A Glaucoma-Specific Brief Motivational Interviewing Training Program for Ophthalmology Para-professionals: Assessment of Feasibility and Initial Patient Impact. Health Communication 35:2, pages 233-241.
Read now
Read now
Sapna Sinha, Daniel Lee, Natasha N. Kolomeyer, Jonathan S. Myers & Reza Razeghinejad. (2020) Fixed combination netarsudil-latanoprost for the treatment of glaucoma and ocular hypertension. Expert Opinion on Pharmacotherapy 21:1, pages 39-45.
Read now
Read now
Stephanie McDonald, Eamonn Ferguson, Martin S Hagger, Alexander J E Foss & Anthony J King. (2019) A theory-driven qualitative study exploring issues relating to adherence to topical glaucoma medications. Patient Preference and Adherence 13, pages 819-828.
Read now
Read now
Alan L. Robin & Kelly W. Muir. (2019) Medication adherence in patients with ocular hypertension or glaucoma. Expert Review of Ophthalmology 14:4-5, pages 199-210.
Read now
Read now
Vardhaman Patel, Ike Ahmed, Dominik Podbielski, Heather Falvey, Judith Murray & Ron Goeree. (2019) Cost-effectiveness analysis of standalone trabecular micro-bypass stents in patients with mild-to-moderate open-angle glaucoma in Canada. Journal of Medical Economics 22:4, pages 390-401.
Read now
Read now
John Thygesen. (2018) Glaucoma therapy: preservative-free for all?. Clinical Ophthalmology 12, pages 707-717.
Read now
Read now
Rebecca Russ Soares & M Reza Razeghinejad. (2018) Efficacy of the combination of carteolol hydrochloride + latanoprost in the treatment of glaucoma and ocular hypertension. Expert Opinion on Pharmacotherapy 19:15, pages 1731-1738.
Read now
Read now
Kamran Rahmatnejad, Jonathan S Myers, Megan E Falls, Sarah R Myers, Michael Waisbourd & Lisa A Hark. (2018) Factors Associated with Patient Satisfaction in an Outpatient Glaucoma Population. Seminars in Ophthalmology 33:6, pages 757-765.
Read now
Read now
Xinghuai Sun, Mingkai Lin, Xuanchu Duan, Chun Zhang & Jian Ming. (2017) Patient satisfaction with fixed-combination bimatoprost/timolol ophthalmic solution: a survey study in patients with glaucoma in China. Patient Preference and Adherence 11, pages 845-852.
Read now
Read now
Francisco José Muñoz Negrete, Hans G Lemij & Carl Erb. (2017) Switching to preservative-free latanoprost: impact on tolerability and patient satisfaction. Clinical Ophthalmology 11, pages 557-566.
Read now
Read now
Jed Asher Lusthaus & Ivan Goldberg. (2017) Brimonidine and brinzolamide for treating glaucoma and ocular hypertension; a safety evaluation. Expert Opinion on Drug Safety 16:9, pages 1071-1078.
Read now
Read now
Andrei-Alexandru Szigiato, Dominik W. Podbielski & Iqbal Ike K. Ahmed. (2017) Sustained drug delivery for the management of glaucoma. Expert Review of Ophthalmology 12:2, pages 173-186.
Read now
Read now
Paul L. Kaufman. (2017) Latanoprostene bunod ophthalmic solution 0.024% for IOP lowering in glaucoma and ocular hypertension. Expert Opinion on Pharmacotherapy 18:4, pages 433-444.
Read now
Read now
Julian García-Feijoo, Francisco J Muñoz-Negrete, Douglas A Hubatsch & Gemma C Rossi. (2016) Efficacy and tolerability of benzalkonium chloride-free travoprost in glaucoma patients switched from benzalkonium chloride-preserved latanoprost or bimatoprost. Clinical Ophthalmology 10, pages 2085-2091.
Read now
Read now
Jed Asher Lusthaus & Ivan Goldberg. (2016) Investigational and experimental drugs for intraocular pressure reduction in ocular hypertension and glaucoma. Expert Opinion on Investigational Drugs 25:10, pages 1201-1208.
Read now
Read now
Zvia Burgansky–Eliash, Elisha Bartov, Adiel Barak, Amiram Grinvald & Dan Gaton. (2016) Blood-Flow Velocity in Glaucoma Patients Measured with the Retinal Function Imager. Current Eye Research 41:7, pages 965-970.
Read now
Read now
Paula Anne Newman-Casey, Megan Dayno & Alan L. Robin. (2016) Systematic review of educational interventions to improve glaucoma medication adherence: an update in 2015. Expert Review of Ophthalmology 11:1, pages 5-20.
Read now
Read now
Jed Asher Lusthaus & Ivan Goldberg. (2016) Emerging drugs to treat glaucoma: targeting prostaglandin F and E receptors. Expert Opinion on Emerging Drugs 21:1, pages 117-128.
Read now
Read now
Kathryn M Berzins, Trish A Gray, Heather Waterman & Jill J Francis. (2015) Specifying active components of educational interventions to promote adherence to treatment in glaucoma patients: application of a taxonomy of behavior change techniques. Psychology Research and Behavior Management 8, pages 201-209.
Read now
Read now
Hans G Lemij, Juliette GMM Hoevenaars, Cees van der Windt & Christophe Baudouin. (2015) Patient satisfaction with glaucoma therapy: reality or myth?. Clinical Ophthalmology 9, pages 785-793.
Read now
Read now
Sourabh Sharma, Sameer Trikha, Shamira A Perera & Tin Aung. (2015) Clinical effectiveness of brinzolamide 1%–brimonidine 0.2% fixed combination for primary open-angle glaucoma and ocular hypertension. Clinical Ophthalmology 9, pages 2201-2207.
Read now
Read now
Quang H Nguyen. (2014) Combination of brinzolamide and brimonidine for glaucoma and ocular hypertension: critical appraisal and patient focus. Patient Preference and Adherence 8, pages 853-864.
Read now
Read now
Albert Alm. (2014) Latanoprost in the treatment of glaucoma. Clinical Ophthalmology 8, pages 1967-1985.
Read now
Read now
Joanna H Campbell, Gail F Schwartz, Britni LaBounty, Jonathan W Kowalski & Vaishali D Patel. (2014) Patient adherence and persistence with topical ocular hypotensive therapy in real-world practice: a comparison of bimatoprost 0.01% and travoprost Z 0.004% ophthalmic solutions. Clinical Ophthalmology 8, pages 927-935.
Read now
Read now
Gábor Holló, Fotis Topouzis & Robert D Fechtner. (2014) Fixed-combination intraocular pressure-lowering therapy for glaucoma and ocular hypertension: advantages in clinical practice. Expert Opinion on Pharmacotherapy 15:12, pages 1737-1747.
Read now
Read now
Cliff Richardson, Lisa Brunton, Nicola Olleveant, David B Henson, Mark Pilling, Jane Mottershead, Cecilia H Fenerty, Anne Fiona Spencer & Heather Waterman. (2013) A study to assess the feasibility of undertaking a randomized controlled trial of adherence with eye drops in glaucoma patients. Patient Preference and Adherence 7, pages 1025-1039.
Read now
Read now
Heather Waterman, Lisa Brunton, Cecilia Fenerty, Jane Mottershead, Cliff Richardson & Fiona Spencer. (2013) Adherence to ocular hypotensive therapy: patient health education needs and views on group education. Patient Preference and Adherence 7, pages 55-63.
Read now
Read now
Raid G. Alany. (2013) Adherence, persistence and cost–consequence comparison of bimatoprost topical ocular formulations. Current Medical Research and Opinion 29:9, pages 1187-1189.
Read now
Read now
Joanna H. Campbell, Gail Schwartz, Britni LaBounty, Jonathan Kowalski & Vaishali D. Patel. (2013) Comparison of adherence and persistence with bimatoprost 0.01% versus bimatoprost 0.03% topical ophthalmic solutions. Current Medical Research and Opinion 29:9, pages 1201-1209.
Read now
Read now
William B. Wong, Vaishali D. Patel, Jonathan W. Kowalski & Gail Schwartz. (2013) An adherence based cost–consequence model comparing bimatoprost 0.01% to bimatoprost 0.03%. Current Medical Research and Opinion 29:9, pages 1191-1200.
Read now
Read now
Articles from other publishers (77)
Victoria Toumanidou, Asterios Diafas, Nikolaos Georgiadis & Ioannis Tsinopoulos. (2023) Fixed versus Unfixed Combination of Topical Latanoprost/Timolol for Glaucoma: An Observational Study Investigating the Level of Adherence and Ocular Surface Health. Journal of Clinical Medicine 12:9, pages 3137.
Crossref
Crossref
Paula Anne Newman-Casey, Ken Resnicow, Suzanne Winter, Leslie M Niziol, Deborah Darnley-Fisch, Nauman Imami, Phalatha McHaney-Conner, David C Musch, Jamie Mitchell & Michele Heisler. (2023) The Support, Educate, Empower personalized glaucoma coaching trial design. Clinical Trials 20:2, pages 192-200.
Crossref
Crossref
Yuening Shen, Jianguo Sun & Xinghuai Sun. (2023) Intraocular nano-microscale drug delivery systems for glaucoma treatment: design strategies and recent progress. Journal of Nanobiotechnology 21:1.
Crossref
Crossref
Olivia J. Killeen, Leslie M. Niziol, Juno Cho, Michele Heisler, Ken Resnicow, Deborah Darnley-Fisch, David C. Musch, Paul P. Lee & Paula Anne Newman-Casey. (2023) Glaucoma Medication Adherence 1 Year after the Support, Educate, Empower Personalized Glaucoma Coaching Program. Ophthalmology Glaucoma 6:1, pages 23-28.
Crossref
Crossref
Andrew M. Williams, Christos Theophanous, Kelly W. Muir, Jullia A. Rosdahl, Sandra Woolson, Maren Olsen, Hayden B. Bosworth & Anna Hung. (2022) Within-Trial Cost-Effectiveness of an Adherence-Enhancing Educational Intervention for Glaucoma. American Journal of Ophthalmology 244, pages 216-227.
Crossref
Crossref
Kerr Brogan, Deus Bigirimana, Antony Wightman, Catherine Green & Keith R. Martin. (2022) Daily Meditation Practice for Managing Glaucoma Patients’ Attitudes and Acceptance. Journal of Glaucoma 31:9, pages e75-e82.
Crossref
Crossref
Sevda Aydin Kurna, Ayse Demirciler Sonmez, Murat Yamic & Ahmet Altun. (2022) Long-term results of micropulse laser trabeculoplasty with 577-nm yellow wavelength in patients with uncontrolled primary open-angle glaucoma and pseudoexfoliation glaucoma. Lasers in Medical Science 37:6, pages 2745-2752.
Crossref
Crossref
Tomislav Sarenac, Anela Bečić Turkanović, Peter Ferme & Tomaž Gračner. (2022) A Review of Selective Laser Trabeculoplasty: “The Hype Is Real”. Journal of Clinical Medicine 11:13, pages 3879.
Crossref
Crossref
Ricardo Augusto Paletta Guedes, Camila Pepe Souza, Leticia Lucia dos Santos Dias, Laura Murta, Daniela Marcelo Gravina & Alfredo Chaoubah. (2022) A Brazilian cost-utility analysis of trabecular micro-bypass with iStent inject® for the treatment of open-angle glaucoma. Revista Brasileira de Oftalmologia 81.
Crossref
Crossref
Hyunsoo J Jang, Brian Yu, William Hodge & Monali S Malvankar-Mehta. (2022) Repeat Selective Laser Trabeculoplasty for Glaucoma Patients: A Systematic Review and Meta-analysis. Journal of Current Glaucoma Practice 15:3, pages 117-124.
Crossref
Crossref
Sylvain Poinard, Thibaud Garcin, Marie-Caroline Trone, Marielle Mentek, Charles Lambert, Paul Bonjean, Didier Renault, Gilles Thuret, Philippe Gain & Anne-Sophie Gauthier. (2022) Objective measurement of adherence to topical steroid medication after penetrating keratoplasty using an electronic monitoring aid: A pilot study. DIGITAL HEALTH 8, pages 205520762211211.
Crossref
Crossref
Yu-Hsiang Shu, Jun Wu, Tiffany Luong, Cynthia Mattox, Ervin N. Fang, Brian L. Lee, Jason P. Jones, Joanna Campbell, Vanessa Shih, Changgeng Zhao & Donald S. Fong. (2021) Topical Medication Adherence and Visual Field Progression in Open-angle Glaucoma: Analysis of a Large US Health Care System. Journal of Glaucoma 30:12, pages 1047-1055.
Crossref
Crossref
Michael J. Gale, Robert M. Kinast, Facundo G. Sanchez & Steven L. Mansberger. (2021) Adherence With Glaucoma Medications: Barriers to Success and Prospects for Improvement. Current Ophthalmology Reports 9:4, pages 184-189.
Crossref
Crossref
Rubén Varela-Fernández, María Isabel Lema-Gesto, Miguel González-Barcia & Francisco Javier Otero-Espinar. (2021) Design, development, and characterization of an idebenone-loaded poly-ε-caprolactone intravitreal implant as a new therapeutic approach for LHON treatment. European Journal of Pharmaceutics and Biopharmaceutics 168, pages 195-207.
Crossref
Crossref
Charis Rousou, Carl C. L. Schuurmans, Arto Urtti, Enrico Mastrobattista, Gert Storm, Chrit Moonen, Kai Kaarniranta & Roel Deckers. (2021) Ultrasound and Microbubbles for the Treatment of Ocular Diseases: From Preclinical Research towards Clinical Application. Pharmaceutics 13:11, pages 1782.
Crossref
Crossref
Ricardo Augusto Paletta Guedes, Camila Pepe, Leticia Dias, Laura Murta, Daniela Marcelo Gravina & Alfredo Chaoubah. (2021) Preventing glaucoma progression using the trabecular micro-bypass implant iStent inject®. A cost-effectiveness analysis. Revista Brasileira de Oftalmologia 80:4.
Crossref
Crossref
Kaspar Nieland, Antoine Labbé, Cedric Schweitzer, Gaetan Gicquel, Joris Kleintjens, Amrita Ostawal, Maarten Treur & Heather Falvey. (2021) A cost-effectiveness analysis of iStent inject combined with phacoemulsification cataract surgery in patients with mild-to-moderate open-angle glaucoma in France. PLOS ONE 16:6, pages e0252130.
Crossref
Crossref
Benjamin van Rooij & D. Daniel Sokol. 2021. The Cambridge Handbook of Compliance. The Cambridge Handbook of Compliance
1
10
.
Ari Leshno, Dan Gaton, Reut Singer, Elior Eliasi, Ofri Vorobichik-Berar, Shiran Madgar, Ori Stern, Wasim Jaber, Noa Kapelushnik & Alon Skaat. (2021) A novel EyePhone© App for improving adherence to glaucoma therapy. Graefe's Archive for Clinical and Experimental Ophthalmology 259:5, pages 1253-1262.
Crossref
Crossref
Chikako ShiraiNobushige MatsuokaToru Nakazawa. (2021) Adherence and Persistence with First-Line Therapy and Compliance with Glaucoma Guidelines Using Japanese Health Care/Pharmacy Claims Database. Journal of Ocular Pharmacology and Therapeutics 37:1, pages 35-44.
Crossref
Crossref
Shunsuke Nakakura, Akiyasu Kanamori, Yasuko Fukuma, Seita Wakabayashi, Yuki Nagata & Miku Adachi. (2021) Evaluation of early medication persistence with omidenepag isopropyl, a topical selective prostaglandin EP2 agonist, in patients with glaucoma: a retrospective two-institute study. BMJ Open 11:1, pages e040301.
Crossref
Crossref
Kevin J. Schneider, Cecilia N. Hollenhorst, Autumn N. Valicevic, Leslie M. Niziol, Michele Heisler, David C. Musch, Stephen M. Cain & Paula-Anne Newman-Casey. (2021) Impact of the Support, Educate, Empower Personalized Glaucoma Coaching Program Pilot Study on Eye Drop Instillation Technique and Self-Efficacy. Ophthalmology Glaucoma 4:1, pages 42-50.
Crossref
Crossref
Kenji Kashiwagi, Eriko Chono, Sarah Koesters & Poh Sin Yap. (2020) Persistence and treatment patterns of fixed combination drugs for glaucoma: a retrospective claims database study in Japan. BMC Ophthalmology 20:1.
Crossref
Crossref
О.В. Павлюченко, Г.Ф. Малиновский & Н.Н. Сиденко. (2020) Optical Coherent Tomography-Angiography in Early Diagnostics and Choosing the Treatment of Primary Open-Angle Glaucoma Treatment. Офтальмология. Восточная Европа:2, pages 230-239.
Crossref
Crossref
Paula Anne Newman-Casey, Leslie M. Niziol, Paul P. Lee, David C. Musch, Kenneth Resnicow & Michele Heisler. (2020) The Impact of the Support, Educate, Empower Personalized Glaucoma Coaching Pilot Study on Glaucoma Medication Adherence. Ophthalmology Glaucoma 3:4, pages 228-237.
Crossref
Crossref
Anthony P. Khawaja, Joanna H. Campbell, Nicholas Kirby, Hitesh S. Chandwani, Ian Keyzor, Mousam Parekh, Andrew I. McNaught, Dubois Vincent, Knox Angela, Anand Nitin, Owora Gbemi, McNaught Andrew & Chang Lydia. (2020) Real-World Outcomes of Selective Laser Trabeculoplasty in the United Kingdom. Ophthalmology 127:6, pages 748-757.
Crossref
Crossref
Matt Shirley. (2020) Bimatoprost Implant: First Approval. Drugs & Aging 37:6, pages 457-462.
Crossref
Crossref
Paula Anne Newman-Casey, Mariam Salman, Paul P. Lee & Justin D. Gatwood. (2020) Cost-Utility Analysis of Glaucoma Medication Adherence. Ophthalmology 127:5, pages 589-598.
Crossref
Crossref
YeJin Lee, SeungHyun Park, Seon Il Kim, KangJu Lee & WonHyoung Ryu. (2020) Rapidly Detachable Microneedles Using Porous Water‐Soluble Layer for Ocular Drug Delivery. Advanced Materials Technologies 5:5, pages 1901145.
Crossref
Crossref
Nolan Payne, Rahul Gangwani, Kira Barton, Alanson P. Sample, Stephen M. Cain, David T. Burke, Paula Anne Newman-Casey & K. Alex Shorter. (2020) Medication Adherence and Liquid Level Tracking System for Healthcare Provider Feedback. Sensors 20:8, pages 2435.
Crossref
Crossref
Victoria L. BartlettPatrick LiuSanket S. DhruvaNilay D. ShahKathryn E. BollingerJoseph S. Ross. (2020) Prostaglandin Coverage and Costs to Medicare and Medicare Beneficiaries, 2009-2017. Journal of Managed Care & Specialty Pharmacy 26:4, pages 562-567.
Crossref
Crossref
Iqbal Ike K. Ahmed, Dominik W. Podbielski, Vardhaman Patel, Heather Falvey, Judith Murray, Marc Botteman & Ron Goeree. (2020) A Canadian Cost-Utility Analysis of 2 Trabecular Microbypass Stents at Time of Cataract Surgery in Patients with Mild to Moderate Open-Angle Glaucoma. Ophthalmology Glaucoma 3:2, pages 103-113.
Crossref
Crossref
E. Randy Craven, Thomas Walters, William C. Christie, Douglas G. Day, Richard A. Lewis, Margot L. Goodkin, Michelle Chen, Veronica Wangsadipura, Michael R. Robinson, Marina Bejanian, Tin Aung, Allen D. Beck, James D. Branch, William C. Christie, Michael Coote, Charles J. Crane, E. Randy Craven, Andrew Crichton, Douglas G. Day, Steven Day, F. Jane Durcan, Richard M. Evans, William J. Flynn, Sébastien Gagné, Damien F. Goldberg, Jack V. Greiner, Paul Jeppsen, Delan Jinapriya, C. Starck Johnson, Shimon Kurtz, Richard A. Lewis, Steven L. Mansberger, Joseph R. Martel, Shamira A. Perera, Michael H. Rotberg, Robert M. Saltzmann, Howard I. Schenker, Michael E. Tepedino, Maria Imelda R. Yap-Veloso, Harvey S. Uy & Thomas R. Walters. (2019) 24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma Patients. Drugs 80:2, pages 167-179.
Crossref
Crossref
Toby S Al-Mugheiry & David C Broadway. (2020) Once-daily Preservative-free Topical Anti-glaucomatous Monotherapy – A Better Approach?. European Ophthalmic Review 14:1, pages 21.
Crossref
Crossref
Marcelo Luís Occhiutto, Raul C. Maranhão, Vital Paulino Costa & Anastasios G. Konstas. (2019) Nanotechnology for Medical and Surgical Glaucoma Therapy—A Review. Advances in Therapy 37:1, pages 155-199.
Crossref
Crossref
Raquel Boia, Paulo A.N. Dias, Joana M. Martins, Caridad Galindo-Romero, Inês D. Aires, Manuel Vidal-Sanz, Marta Agudo-Barriuso, Hermínio C. de Sousa, António Francisco Ambrósio, Mara E.M. Braga & Ana Raquel Santiago. (2019) Porous poly(ε-caprolactone) implants: A novel strategy for efficient intraocular drug delivery. Journal of Controlled Release 316, pages 331-348.
Crossref
Crossref
Monika Yadav, Ana Guzman-Aranguez, Maria J. Perez de Lara, Mandeep Singh, Joga Singh & Indu Pal Kaur. (2019) Bimatoprost loaded nanovesicular long-acting sub-conjunctival in-situ gelling implant: In vitro and in vivo evaluation. Materials Science and Engineering: C 103, pages 109730.
Crossref
Crossref
Robert N. Weinreb, Jason Bacharach, Robert D. Fechtner, Malik Y. Kahook, David Wirta, Steve Burmaster, Xiangyi Meng & Douglas A. Hubatsch. (2019) 24-Hour Intraocular Pressure Control with Fixed-dose Combination Brinzolamide 1%/Brimonidine 0.2%. Ophthalmology 126:8, pages 1095-1104.
Crossref
Crossref
Yiqi Cao, Karen E. Samy, Daniel A. Bernards & Tejal A. Desai. (2019) Recent advances in intraocular sustained-release drug delivery devices. Drug Discovery Today 24:8, pages 1694-1700.
Crossref
Crossref
Jae Hwan Jung, J. Jeremy Chae & Mark R. Prausnitz. (2019) Targeting drug delivery within the suprachoroidal space. Drug Discovery Today 24:8, pages 1654-1659.
Crossref
Crossref
Aaron M. Hein, Jullia A. Rosdahl, Hayden B. Bosworth, Sandra L. Woolson, Maren K. Olsen, Miriam A. Kirshner & Kelly W. Muir. (2019) The Relationship of Self-Report and Medication Possession With Glaucoma Medication Administration Success. Journal of Glaucoma 28:3, pages e46-e48.
Crossref
Crossref
Sascha K.R. Spencer, Boaz Shulruf, Zachary E. McPherson, Helen Zhang, Mitchell B. Lee, Ian C. Francis, Allan Bank, Minas T. Coroneo & Ashish Agar. (2019) Factors Affecting Adherence to Topical Glaucoma Therapy. Ophthalmology Glaucoma 2:2, pages 86-93.
Crossref
Crossref
Jennifer R. SealMichael R. RobinsonJames BurkeMarina BejanianMichael CooteMayssa Attar. (2019) Intracameral Sustained-Release Bimatoprost Implant Delivers Bimatoprost to Target Tissues with Reduced Drug Exposure to Off-Target Tissues. Journal of Ocular Pharmacology and Therapeutics 35:1, pages 50-57.
Crossref
Crossref
Toyoaki Tsumura, Kenji Kashiwagi, Yasuyuki Suzuki, Keiji Yoshikawa, Hirotaka Suzumura, Toshine Maeda, Ryuji Takeda, Hitomi Saito & Makoto Araie. (2018) A nationwide survey of factors influencing adherence to ocular hypotensive eyedrops in Japan. International Ophthalmology 39:2, pages 375-383.
Crossref
Crossref
Richard FiscellaEleanor CaplanPravin KambleSuvapun BunniranClaudia UribeHitesh Chandwani. (2018) The Effect of an Educational Intervention on Adherence to Intraocular Pressure-Lowering Medications in a Large Cohort of Older Adults with Glaucoma. Journal of Managed Care & Specialty Pharmacy 24:12, pages 1284-1294.
Crossref
Crossref
Paula Anne Newman-Casey, Leslie M. Niziol, Chamisa K. Mackenzie, Kenneth Resnicow, Paul P. Lee, David C. Musch & Michele Heisler. (2018) Personalized behavior change program for glaucoma patients with poor adherence: a pilot interventional cohort study with a pre-post design. Pilot and Feasibility Studies 4:1.
Crossref
Crossref
Karen Chan Suet Yee, Low Jing Wen, Chang Chee Tao, Hoo Fun Wee, Lee Siew Huang & Huan-Keat Chan. (2018) Adherence and challenges in administering eye medications among glaucoma patients in a Malaysian public tertiary care centre. Journal of Pharmaceutical Health Services Research 9:4, pages 361-365.
Crossref
Crossref
Paula Anne Newman-CaseyOlivia J. KilleenMorgan RennerAlan L. RobinPaul LeeMichele Heisler. (2018) Access to and Experiences with, e-Health Technology Among Glaucoma Patients and Their Relationship with Medication Adherence. Telemedicine and e-Health 24:12, pages 1026-1035.
Crossref
Crossref
Justin D. Gatwood, Jordan Johnson & Brian Jerkins. (2017) Comparisons of Self-reported Glaucoma Medication Adherence With a New Wireless Device. Journal of Glaucoma 26:11, pages 1056-1061.
Crossref
Crossref
Elizabeth A. CairnsAnna-Maria SzczesniakAlex J. StraikerPushkar M. KulkarniRoger G. PertweeGanesh A. ThakurWilliam H. BaldridgeMelanie E.M. Kelly. (2017)
The
In Vivo
Effects of the CB
1
-Positive Allosteric Modulator GAT229 on Intraocular Pressure in Ocular Normotensive and Hypertensive Mice
. Journal of Ocular Pharmacology and Therapeutics 33:8, pages 582-590.
Crossref
Crossref
Chun Gwon Park, Young Kook Kim, Se-Na Kim, Seung Ho Lee, Beom Kang Huh, Min-A Park, Hyein Won, Ki Ho Park & Young Bin Choy. (2017) Enhanced ocular efficacy of topically-delivered dorzolamide with nanostructured mucoadhesive microparticles. International Journal of Pharmaceutics 522:1-2, pages 66-73.
Crossref
Crossref
Howard S. Barnebey & Alan L. Robin. (2017) Adherence to Fixed-Combination Versus Unfixed Travoprost 0.004%/Timolol 0.5% for Glaucoma or Ocular Hypertension: A Randomized Trial. American Journal of Ophthalmology 176, pages 61-69.
Crossref
Crossref
Jianguo Sun, Yuan Lei, Zhaoxing Dai, Xi Liu, Taomin Huang, Jihong Wu, Zhi Ping Xu & Xinghuai Sun. (2017) Sustained Release of Brimonidine from a New Composite Drug Delivery System for Treatment of Glaucoma. ACS Applied Materials & Interfaces 9:9, pages 7990-7999.
Crossref
Crossref
Rachel L.R. GomesRodrigo Galvão VianaLuiz Alberto S. MeloJr.Jr., Alessandro Carvalho CruzEunice Mayumi SuenagaKenneth R. KenyonMauro Campos. (2017) Aqueous Humor Penetration and Biological Activity of Moxifloxacin 0.5% Ophthalmic Solution Alone or with Dexamethasone 0.1%. Journal of Ocular Pharmacology and Therapeutics 33:2, pages 98-102.
Crossref
Crossref
Eva M. del Amo, Anna-Kaisa Rimpelä, Emma Heikkinen, Otto K. Kari, Eva Ramsay, Tatu Lajunen, Mechthild Schmitt, Laura Pelkonen, Madhushree Bhattacharya, Dominique Richardson, Astrid Subrizi, Tiina Turunen, Mika Reinisalo, Jaakko Itkonen, Elisa Toropainen, Marco Casteleijn, Heidi Kidron, Maxim Antopolsky, Kati-Sisko Vellonen, Marika Ruponen & Arto Urtti. (2017) Pharmacokinetic aspects of retinal drug delivery. Progress in Retinal and Eye Research 57, pages 134-185.
Crossref
Crossref
Nicholas J. D. Gower, Robert J. Barry, Matthew R. Edmunds, Lucy C. Titcomb & Alastair K. Denniston. (2016) Drug discovery in ophthalmology: past success, present challenges, and future opportunities. BMC Ophthalmology 16:1.
Crossref
Crossref
Kevin D. Lance, Daniel A. Bernards, Natalie A. Ciaccio, Samuel D. Good, Thaís S. Mendes, Max Kudisch, Elliot Chan, Mynna Ishikiriyama, Robert B. Bhisitkul & Tejal A. Desai. (2016) In vivo and in vitro sustained release of ranibizumab from a nanoporous thin-film device. Drug Delivery and Translational Research 6:6, pages 771-780.
Crossref
Crossref
Manon Belhassen, Laurent Laforest, Idlir Licaj & Éric Van Ganse. (2016) Étude observationnelle sur l’adhésion précoce aux traitements hypotonisants anti-glaucomateux. Therapies 71:5, pages 491-499.
Crossref
Crossref
Richard SheerSuvapun BunniranClaudia UribeRichard G. FiscellaVaishali D. PatelHitesh S. Chandwani. (2016) Predictors of Nonadherence to Topical Intraocular Pressure Reduction Medications Among Medicare Members: A Claims-Based Retrospective Cohort Study. Journal of Managed Care & Specialty Pharmacy 22:7, pages 808-817.
Crossref
Crossref
B. Chiang, Y.C. Kim, A.C. Doty, H.E. Grossniklaus, S.P. Schwendeman & M.R. Prausnitz. (2016) Sustained reduction of intraocular pressure by supraciliary delivery of brimonidine-loaded poly(lactic acid) microspheres for the treatment of glaucoma. Journal of Controlled Release 228, pages 48-57.
Crossref
Crossref
Joao F. Lopes, Douglas A. Hubatsch & Patricia Amaris. (2015) Effect of benzalkonium chloride–free travoprost on intraocular pressure and ocular surface symptoms in patients with glaucoma previously on latanoprost: an open-label study. BMC Ophthalmology 15:1.
Crossref
Crossref
Chun Gwon Park, Young Kook Kim, Mi Jeung Kim, Min Park, Myung Hun Kim, Seung Ho Lee, Sung Yoon Choi, Won Seok Lee, You Jung Chung, Young Eun Jung, Ki Ho Park & Young Bin Choy. (2015) Mucoadhesive microparticles with a nanostructured surface for enhanced bioavailability of glaucoma drug. Journal of Controlled Release 220, pages 180-188.
Crossref
Crossref
Karsten Voss, Karen Falke, Arne Bernsdorf, Niels Grabow, Christian Kastner, Katrin Sternberg, Ingo Minrath, Thomas Eickner, Andreas Wree, Klaus-Peter Schmitz, Rudolf Guthoff, Martin Witt & Marina Hovakimyan. (2015) Development of a novel injectable drug delivery system for subconjunctival glaucoma treatment. Journal of Controlled Release 214, pages 1-11.
Crossref
Crossref
Robyn Sayner, Delesha M. Carpenter, Susan J. Blalock, Alan L. Robin, Kelly W. Muir, Mary Elizabeth Hartnett, Annette L. Giangiacomo, Gail Tudor & Betsy Sleath. (2015) Accuracy of Patient-reported Adherence to Glaucoma Medications on a Visual Analog Scale Compared With Electronic Monitors. Clinical Therapeutics 37:9, pages 1975-1985.
Crossref
Crossref
O. G. Gusarevich, A. E. Nurlanbayeva, A. A. Gusarevich, A. Zh. Fursova, O. G. Fen’kova & S. V. Aydagulova. (2015) Ultrasound biomicroscopy findings in the area of previous surgical intervention in refractory glaucoma patients under topical ocular hypotensive therapy. Vestnik oftal'mologii 131:3, pages 45.
Crossref
Crossref
Yoo Chun Kim, Bryce Chiang, Xianggen Wu & Mark R. Prausnitz. (2014) Ocular delivery of macromolecules. Journal of Controlled Release 190, pages 172-181.
Crossref
Crossref
Arturo Alezzandrini, Douglas Hubatsch & Rene Alfaro. (2014) Efficacy and Tolerability of Fixed-Combination Brinzolamide/Timolol in Latin American Patients with Open-Angle Glaucoma or Ocular Hypertension Previously on Brimonidine/Timolol Fixed Combination. Advances in Therapy 31:9, pages 975-985.
Crossref
Crossref
Penelope Stanford, Nicola Olleveant & Lihua Wu. (2014) Traditional Chinese medicine, health beliefs and glaucoma awareness: implications for UK practice. International Journal of Ophthalmic Practice 5:4, pages 134-138.
Crossref
Crossref
Kenji Kashiwagi & Toshie Furuya. (2013) Persistence with topical glaucoma therapy among newly diagnosed Japanese patients. Japanese Journal of Ophthalmology 58:1, pages 68-74.
Crossref
Crossref
John EA Somner, Freda Sii, Rupert Bourne, Vinette Cross & Peter Shah. (2013) What do patients with glaucoma think about personal health records?. Ophthalmic and Physiological Optics 33:6, pages 627-633.
Crossref
Crossref
Ernst R. Tamm, Franz Grehn & Norbert Pfeiffer. (2013) Neuroprotection in glaucoma. Cell and Tissue Research 353:2, pages 201-203.
Crossref
Crossref
Ernst R. Tamm, Leopold Schmetterer & Franz Grehn. (2013) Status and perspectives of neuroprotective therapies in glaucoma: The European Glaucoma Society White Paper. Cell and Tissue Research 353:2, pages 347-354.
Crossref
Crossref
PNINA FISHMAN, SHIRA COHEN & SARA BAR-YEHUDA. (2013) Targeting the A3 adenosine receptor for glaucoma treatment (Review). Molecular Medicine Reports 7:6, pages 1723-1725.
Crossref
Crossref
Daniel W. Pita-Thomas & Jeffrey L. Goldberg. (2013) Nanotechnology and glaucoma. Current Opinion in Ophthalmology 24:2, pages 130-135.
Crossref
Crossref
Jimmy S.M. Lai & Clement C.Y. Tham. (2013) Medication Adherence in Glaucoma Patients. Asia-Pacific Journal of Ophthalmology 2:6, pages 354-355.
Crossref
Crossref
Simon E. Skalicky & Ivan Goldberg. (2013) Adherence and Persistence. Asia-Pacific Journal of Ophthalmology 2:6, pages 356-361.
Crossref
Crossref
Marcelo L. Occhiutto, Fatima R. Freitas, Raul C. Maranhao & Vital P. Costa. (2012) Breakdown of the Blood-Ocular Barrier as a Strategy for the Systemic Use of Nanosystems. Pharmaceutics 4:2, pages 252-275.
Crossref
Crossref